
    
      Concurrent chemoradiation is the standard treatment for locally advanced NPC. The survival
      benefit gained from adding neoadjuvant chemotherapy to concurrent chemoradiation has never
      been defined. In the present trail, we hope to assess the tolerance and survival benefits of
      neoadjuvant chemotherapy followed by concurrent chemoradiation in patients with stage â…¢ NPC.
    
  